Intradermal immunization with ovalbumin‐loaded poly‐ɛ‐caprolactone microparticles conferred protection in ovalbumin‐sensitized allergic mice
- 23 January 2007
- journal article
- Published by Wiley in Clinical & Experimental Allergy
- Vol. 37 (2) , 287-295
Abstract
Summary: Background Although immunotherapy has been reported as the only treatment able to revert the T‐helper type 2 (Th2) response, its administration has some disadvantages such as the requirement of multiple doses, possible side‐effects provoked by conventional adjuvants and the risk of suffering an anaphylactic shock. For these reasons, drug‐delivery systems appear to be a promising strategy due to its ability to (i) transport the allergens, (ii) protect them from degradation, (iii) decrease the number of administrations and (iv) act as immuno‐adjuvants.Objective The aim of this work was to evaluate the properties of poly‐ɛ‐caprolactone (PCL) microparticles as adjuvants in immunotherapy using ovalbumin (OVA) as an allergen model. For this purpose, the protection capacity of these microparticles (OVA PCL) against OVA allergy was studied in a murine model.Methods The humoral and cellular‐induced immune response generated by OVA encapsulated into PCL microparticles was studied by immunizing BALB/c mice intradermically. Also, OVA‐sensitized mice were treated with OVA PCL and OVA adsorbed to aluminium hydroxide (OVA‐Alum). Fifteen days after therapy, animals were challenged with OVA and different signs of anaphylactic shock were evaluated.Results One single shot by an intradermal route with OVA PCL resulted in a Th2‐type immune response. In OVA‐sensitized mice, treatment with OVA PCL elicited high OVA‐specific IgG but low levels of IgE. Furthermore, OVA PCL mice group displayed lower levels of serum histamine and higher survival rate in comparison with the positive control group.Conclusion The anaphylactic shock suffered by OVA PCL‐treated mice was weaker than the one induced in the OVA‐Alum group. Hence, the intradermal immunization with OVA PCL microparticles induced hyposensitization in OVA‐allergic mice.Keywords
This publication has 31 references indexed in Scilit:
- Lounging in a lysosome: the intracellular lifestyle of Coxiella burnetiiCellular Microbiology, 2007
- The safety of immunotherapyClinical & Experimental Allergy, 2004
- A prolonged immune response to antigen delivered in poly (∊‐caprolactone) microparticlesImmunology & Cell Biology, 2003
- Optimization of Route of Administration for Coexposure to Ovalbumin and Particle Matter to Induce Adjuvant Activity in Respiratory Allergy in the MouseInhalation Toxicology, 2003
- A murine model of IgE-mediated cow’s milk hypersensitivityJournal of Allergy and Clinical Immunology, 1999
- Allergen immunotherapy decreases interleukin 4 production in CD4+ T cells from allergic individuals.Journal of Experimental Medicine, 1993
- Effect of homogenization and pasteurization on the allergenicity of bovine milk analysed by a murine anaphylactic shock modelClinical & Experimental Allergy, 1987
- Diagnosis and Immunotherapy of Mould AllergyAllergy, 1986
- Contact sensitivity to aluminium in a patient hyposensitized with aluminium precipitated grass pollenContact Dermatitis, 1980
- Electrophoretic analysis of the major polypeptides of the human erythrocyte membraneBiochemistry, 1971